At Ind-Swift Limited, our dedicated Quality Unit ensures that every product we manufacture meets the highest standards of safety, efficacy, and reliability. With a strong commitment to excellence, our team follows rigorous Quality Control (QC) and Quality Assurance (QA) protocols to ensure compliance with global regulatory requirements.
The Quality Department functions independently from production and other departments to maintain objectivity and uphold our unwavering commitment to pharmaceutical quality.
Our Quality Unit is composed of skilled professionals who collaborate across multiple departments to oversee the entire lifecycle of each product—from research and development through manufacturing, packaging, and distribution. We continuously monitor systems and processes to ensure consistency, safety, and the highest quality standards.
To become a trusted leader in delivering high-quality pharmaceutical products — both in domestic and international markets — through continuous system development and improvement.
At Ind-Swift Limited, we are committed to maintaining the highest standards of quality and regulatory compliance. Our manufacturing site undergoes regular audits and inspections by global regulatory bodies to ensure that we adhere to all applicable laws, guidelines, and standards.
Our commitment to regulatory excellence is validated through successful audits by a number of prestigious organizations, including:
Site is also accredited by FDA Philippines, FMHACA Ethiopia, TGA Australia, MOH Yemen, NDA Uganda and Ministry of Public Health Afghanistan
The regulatory audits and inspections we undergo are a testament to our commitment to quality, safety, and compliance. These rigorous reviews ensure that we continue to meet the highest industry standards and regulatory expectations, providing our customers and partners with the confidence that our products are of the highest quality and safety.
We believe that maintaining high standards is a shared responsibility. To nurture a sustainable culture of quality, we invest in the continuous training, upskilling, and empowerment of our employees. Our goal is to harmonize and simplify our GxP processes, ensuring every stakeholder is aligned with our quality-first approach.
From development to delivery, every product that leaves an Ind-Swift facility is a testament to our uncompromising commitment to quality.
The strength of our analytical equipment plays a critical role in our ability to produce high-quality, compliant products. By leveraging the latest technologies.
Key Analytical Instruments
The Quality Unit at Ind-Swift ensures that all products meet the highest standards of safety, efficacy, and reliability through strict quality control (QC) and quality assurance (QA) protocols.
The Quality Department operates independently from production to maintain transparency and compliance, working across R&D, manufacturing, packaging, and distribution.
Our site has been audited and approved by MHRA (UK), Health Canada, ROF (Germany), HLfGP (Hessen), FDA Punjab, CDSCO India, and Ministries of Health from Oman, Iraq, Philippines, Ethiopia, Australia, Yemen, Uganda, and Afghanistan.
We undergo regular inspections and audits by international and national regulatory bodies to ensure ongoing compliance with global pharmaceutical standards.
We use industry-leading instruments such as HPLC, UPLC, Gas Chromatography, FTIR, UV Spectrophotometer, Atomic Absorption Spectroscopy, and Dissolution Apparatus.
Our team of skilled professionals monitors every stage of the product lifecycle—from development to distribution—using validated systems and equipment.
Regulatory compliance ensures that our manufacturing practices meet international laws and guidelines, building confidence in the quality and safety of our products.
Our Quality and Regulatory teams stay informed of evolving global standards and implement updates promptly to maintain full compliance and product excellence.
Independence allows for unbiased monitoring and decision-making, ensuring that no compromises are made on product quality, patient safety, or regulatory adherence.